FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
Biotechnology | CMO | CRO | Genomics | Therapeutics | Vaccine
Samsung Biologics Expands U.S. Manufacturing Capabilities with Acquisition of Human Genome Sciences from GSK
On Dec. 21, 2025, Samsung Biologics announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered…
FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…
Biotechnology | Diagnostics | HIV | Therapeutics | Vaccine | WHO | Women's Health
WHO validates Brazil for eliminating mother-to-child transmission of HIV
On Dec. 18, 2025, the World Health Organization (WHO) announced it has validated Brazil for the elimination of…
Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 Years
On Dec. 18, 2025, new national and state data was released by the Partnership to Fight Chronic Disease…
Space Station Research Supports New FDA-Approved Cancer Therapy
On Dec. 18, 2025, the National Aeronautics and Space Administration (NASA) announced it has opened the International Space…
Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
On Dec. 18, 2025, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S….
Israeli, US scientists uncover viral switch that could help defeat antibiotic resistance
On Dec. 18, 2025, scientists at the Hebrew University of Jerusalem revealed that bacteriophages use a small RNA…
University Engineers create robots barely visible to the naked eye that operate autonomously
On Dec. 17, 2025, researchers at the University of Pennsylvania’s (UPenn) School of Engineering and Applied Science, and…
Adaptive Inks deals with Pfizer to support research in rheumatoid arthritis and other immune-related diseases woth $890 Million
On Dec. 15, 2025, Adaptive Biotechnologies announced it has signed two non-exclusive deals with Pfizer to support research…
Biotechnology | Disease | FDA | Therapeutics
FDA Approves Two Oral Therapies to Treat Gonorrhea
On Dec. 12, 2025, the U.S. Food and Drug Administration (FDA) announced it has approved two new oral…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
FDA Approves USAntibiotics’ Augmentin XR in Historic First for Expedited Review Program
On Dec. 11, 2025, USAntibiotics, the country’s only domestic manufacturer of amoxicillin (Amoxil®) and amoxicillin clavulanate (Augmentin®), announced…
FDA | Medicine | Therapeutics
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
On Dec. 9, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the…
UCLA team discovers how to target ‘undruggable’ protein that fuels aggressive leukemia
On Dec. 9, 2025, researchers at the UCLA Health Jonsson Comprehensive Cancer Center announced they have identified a…
Agriculture | Artificial Intelligence | Biotechnology | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Stem Cell | Therapeutics | Vaccine
Canada launches $1.7 billion initiative to recruit world-leading researchers
On Dec. 9, 2025, officials from the Canada Economic Development for Quebec Regions, and the Minister of Industry,…
Biotechnology | CRISPR | Disease | FDA | Genomics | Stem Cell | Therapeutics
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
On Dec. 8, 2025, the U.S. Food and Drug Administration (FDA) approved two milestone treatments, Casgevy and Lyfgenia,…
Agriculture | Artificial Intelligence | Biotechnology | Chemistry | Clinical Research | Energy | Environmental | Genomics | Nanotechnology | Neurology | Organ Transplant | Pharmaceutical | Stem Cell | Therapeutics | Vaccine
China narrows US’ scientific research lead
On Dec. 5, 2025, an annual report published by the Institutes of Science and Development of the Chinese…
Merck Product first in its class and the only product conditionally approved by FDA for both prevention and treatment of New World screwworm
On Dec. 4, 2025, Merck Animal Health announced the U.S. Food and Drug Administration (FDA) has granted a…
Disease | Infectious Disease | Measles | Medicine | Non-Profit Research | Therapeutics | Vaccine | WHO | Women's Health
Nearly one in five child deaths linked to growth failure
On Dec. 2, 2025, findings in the latest Global Burden of Disease 2023 study published in The Lancet…
Biotechnology | Cardiology | Disease | Therapeutics | WHO
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
On Dec. 1, 2025, the World Health Organization (WHO) has released its first guideline on the use of…
Anonymous donor gifts $50M to help University of Washington train ‘unsung heroes’ of healthcare
On Dec. 1, 2025, in an unusual act of philanthropy, an anonymous donor has committed more than $50…
Artificial Intelligence | Biology | Diagnostics | Disease | Medicine | Pharmaceutical | Therapeutics
MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
On Nov. 24, 2025, a new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy…
New AI model could speed rare disease diagnosis
On Nov. 24, 2025, a new AI model called popEVE developed by Harvard Medical School researchers and colleagues…
CDC | Clinical Research | HIV | Infectious Disease | Medicine | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Veterinary
U.S. Centers for Disease Control and Prevention to End Monkey Research Program
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
WHO Reports Diphtheria outbreak in African Region
On Nov. 21, 2025, the World Health Organization (WHO) reported that from 1 January to 2 November 2025,…
Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…